IndraLab

Statements

USP32 decreases the amount of SLC35F2. 1 / 1

| 1

reach

"Therefore, inhibition of USP32 can increase the protein expression of SLC35F2 and improve the chemotherapeutic effect of YM155 on breast cancer, opening up a new pathway for clinical drug resistance treatment."

37679322

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP32 decreases the amount of SLC35F2. 1 / 1

INDRA sources:

Databases

Reading